Shares of Moderna Inc.
MRNA,
sank 0.42% to $150.33 Monday, on what proved to be an all-around dismal buying and selling session for the inventory market, with the NASDAQ Composite Index
COMP,
falling 1.03% to 10,988.15 and Dow Jones Industrial Common
DJIA,
falling 0.39% to 32,732.95. The inventory’s fall snapped a six-day profitable streak. Moderna Inc. closed $226.32 in need of its 52-week excessive ($376.65), which the corporate reached on November twenty ninth.
The inventory demonstrated a combined efficiency when in comparison with a few of its opponents Monday, as AbbVie Inc.
ABBV,
fell 0.82% to $146.40, Amgen Inc.
AMGN,
fell 1.26% to $270.35, and AstraZeneca PLC ADR
AZN,
rose 0.17% to $58.81. Buying and selling quantity (3.6 M) remained 1.3 million under its 50-day common quantity of 4.9 M.
Editor’s Notice: This story was auto-generated by Automated Insights, an automation expertise supplier, utilizing knowledge from Dow Jones and FactSet. See our market knowledge phrases of use.
